metaraminol has been researched along with Central Nervous System Origin Vertigo in 2 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BARBIERI, C | 1 |
| SAVIOLI, F | 1 |
| HORLER, AR | 1 |
| WYNNE, NA | 1 |
2 other studies available for metaraminol and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
[CLINICAL EXPERIENCE WITH METARAMINOL].
Topics: Humans; Hypotension; Hypotension, Orthostatic; Metaraminol; Posture; Vertigo | 1964 |
HYPERTENSIVE CRISIS DUE TO PARGYLINE AND METARAMINOL.
Topics: Autonomic Nervous System Diseases; Drug Synergism; Drug Therapy; Headache; Hypertension; Metaraminol | 1965 |